Logo image of JCI

JOHNSON CONTROLS INTERNATION (JCI) Stock Fundamental Analysis

NYSE:JCI - New York Stock Exchange, Inc. - IE00BY7QL619 - Common Stock - Currency: USD

101.54  -2.06 (-1.99%)

Fundamental Rating

4

Taking everything into account, JCI scores 4 out of 10 in our fundamental rating. JCI was compared to 42 industry peers in the Building Products industry. JCI has a medium profitability rating, but doesn't score so well on its financial health evaluation. JCI is quite expensive at the moment. It does show a decent growth rate. Finally JCI also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

JCI had positive earnings in the past year.
JCI had a positive operating cash flow in the past year.
In the past 5 years JCI has always been profitable.
In the past 5 years JCI always reported a positive cash flow from operatings.
JCI Yearly Net Income VS EBIT VS OCF VS FCFJCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

JCI's Return On Assets of 5.91% is in line compared to the rest of the industry. JCI outperforms 42.86% of its industry peers.
With a Return On Equity value of 15.85%, JCI perfoms like the industry average, outperforming 59.52% of the companies in the same industry.
JCI's Return On Invested Capital of 7.89% is on the low side compared to the rest of the industry. JCI is outperformed by 61.90% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JCI is significantly below the industry average of 12.71%.
The last Return On Invested Capital (7.89%) for JCI is above the 3 year average (6.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.91%
ROE 15.85%
ROIC 7.89%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%
JCI Yearly ROA, ROE, ROICJCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

JCI has a better Profit Margin (11.78%) than 69.05% of its industry peers.
JCI's Profit Margin has declined in the last couple of years.
JCI has a Operating Margin (14.94%) which is comparable to the rest of the industry.
JCI's Operating Margin has improved in the last couple of years.
JCI's Gross Margin of 37.15% is in line compared to the rest of the industry. JCI outperforms 59.52% of its industry peers.
In the last couple of years the Gross Margin of JCI has grown nicely.
Industry RankSector Rank
OM 14.94%
PM (TTM) 11.78%
GM 37.15%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%
JCI Yearly Profit, Operating, Gross MarginsJCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so JCI is still creating some value.
Compared to 1 year ago, JCI has less shares outstanding
The number of shares outstanding for JCI has been reduced compared to 5 years ago.
JCI has a worse debt/assets ratio than last year.
JCI Yearly Shares OutstandingJCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
JCI Yearly Total Debt VS Total AssetsJCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

An Altman-Z score of 2.30 indicates that JCI is not a great score, but indicates only limited risk for bankruptcy at the moment.
JCI has a Altman-Z score of 2.30. This is in the lower half of the industry: JCI underperforms 78.57% of its industry peers.
JCI has a debt to FCF ratio of 3.43. This is a good value and a sign of high solvency as JCI would need 3.43 years to pay back of all of its debts.
JCI has a Debt to FCF ratio (3.43) which is in line with its industry peers.
JCI has a Debt/Equity ratio of 0.60. This is a neutral value indicating JCI is somewhat dependend on debt financing.
JCI has a Debt to Equity ratio (0.60) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 3.43
Altman-Z 2.3
ROIC/WACC1.09
WACC7.25%
JCI Yearly LT Debt VS Equity VS FCFJCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

JCI has a Current Ratio of 0.96. This is a bad value and indicates that JCI is not financially healthy enough and could expect problems in meeting its short term obligations.
JCI has a Current ratio of 0.96. This is amonst the worse of the industry: JCI underperforms 92.86% of its industry peers.
JCI has a Quick Ratio of 0.96. This is a bad value and indicates that JCI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.81, JCI is doing worse than 80.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.81
JCI Yearly Current Assets VS Current LiabilitesJCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

JCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.13%, which is quite good.
Measured over the past years, JCI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.04% on average per year.
JCI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.76%.
Measured over the past years, JCI shows a decrease in Revenue. The Revenue has been decreasing by -0.86% on average per year.
EPS 1Y (TTM)15.13%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%5.13%
Revenue 1Y (TTM)-20.76%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-15.27%

3.2 Future

JCI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.04% yearly.
Based on estimates for the next years, JCI will show a small growth in Revenue. The Revenue will grow by 2.66% on average per year.
EPS Next Y-0.86%
EPS Next 2Y7.41%
EPS Next 3Y9.94%
EPS Next 5Y11.04%
Revenue Next Year-11.14%
Revenue Next 2Y-3.5%
Revenue Next 3Y-1.12%
Revenue Next 5Y2.66%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JCI Yearly Revenue VS EstimatesJCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
JCI Yearly EPS VS EstimatesJCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.17, JCI can be considered very expensive at the moment.
Based on the Price/Earnings ratio, JCI is valued a bit more expensive than 64.29% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.60, JCI is valued at the same level.
With a Price/Forward Earnings ratio of 23.72, JCI is valued on the expensive side.
64.29% of the companies in the same industry are cheaper than JCI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.39, JCI is valued at the same level.
Industry RankSector Rank
PE 26.17
Fwd PE 23.72
JCI Price Earnings VS Forward Price EarningsJCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JCI is valued a bit more expensive than 71.43% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as JCI.
Industry RankSector Rank
P/FCF 22.95
EV/EBITDA 19.41
JCI Per share dataJCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.01
EPS Next 2Y7.41%
EPS Next 3Y9.94%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.45%, JCI has a reasonable but not impressive dividend return.
JCI's Dividend Yield is rather good when compared to the industry average which is at 1.20. JCI pays more dividend than 83.33% of the companies in the same industry.
JCI's Dividend Yield is slightly below the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.45%

5.2 History

The dividend of JCI is nicely growing with an annual growth rate of 6.63%!
JCI has paid a dividend for at least 10 years, which is a reliable track record.
JCI has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)6.63%
Div Incr Years4
Div Non Decr Years7
JCI Yearly Dividends per shareJCI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

JCI pays out 39.36% of its income as dividend. This is a sustainable payout ratio.
The dividend of JCI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP39.36%
EPS Next 2Y7.41%
EPS Next 3Y9.94%
JCI Yearly Income VS Free CF VS DividendJCI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B
JCI Dividend Payout.JCI Dividend Payout, showing the Payout Ratio.JCI Dividend Payout.PayoutRetained Earnings

JOHNSON CONTROLS INTERNATION

NYSE:JCI (6/13/2025, 2:49:10 PM)

101.54

-2.06 (-1.99%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners93.1%
Inst Owner Change-0.15%
Ins Owners0.27%
Ins Owner Change-4.68%
Market Cap66.82B
Analysts77.04
Price Target104 (2.42%)
Short Float %1.43%
Short Ratio1.98
Dividend
Industry RankSector Rank
Dividend Yield 1.45%
Yearly Dividend1.49
Dividend Growth(5Y)6.63%
DP39.36%
Div Incr Years4
Div Non Decr Years7
Ex-Date03-24 2025-03-24 (0.37)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.4%
Min EPS beat(2)3.16%
Max EPS beat(2)7.63%
EPS beat(4)4
Avg EPS beat(4)5.16%
Min EPS beat(4)3.16%
Max EPS beat(4)7.63%
EPS beat(8)5
Avg EPS beat(8)2.05%
EPS beat(12)6
Avg EPS beat(12)1.3%
EPS beat(16)7
Avg EPS beat(16)0.84%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.26%
Max Revenue beat(2)1.59%
Revenue beat(4)2
Avg Revenue beat(4)0.25%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)2.04%
Revenue beat(8)2
Avg Revenue beat(8)-0.9%
Revenue beat(12)3
Avg Revenue beat(12)-1.15%
Revenue beat(16)5
Avg Revenue beat(16)-1%
PT rev (1m)12.72%
PT rev (3m)7.69%
EPS NQ rev (1m)-0.1%
EPS NQ rev (3m)-1.04%
EPS NY rev (1m)1.18%
EPS NY rev (3m)0.54%
Revenue NQ rev (1m)0.58%
Revenue NQ rev (3m)0.6%
Revenue NY rev (1m)1.28%
Revenue NY rev (3m)1.5%
Valuation
Industry RankSector Rank
PE 26.17
Fwd PE 23.72
P/S 3.14
P/FCF 22.95
P/OCF 19.71
P/B 4.23
P/tB N/A
EV/EBITDA 19.41
EPS(TTM)3.88
EY3.82%
EPS(NY)4.28
Fwd EY4.22%
FCF(TTM)4.42
FCFY4.36%
OCF(TTM)5.15
OCFY5.07%
SpS32.31
BVpS24.02
TBVpS-6.97
PEG (NY)N/A
PEG (5Y)2.01
Profitability
Industry RankSector Rank
ROA 5.91%
ROE 15.85%
ROCE 10.4%
ROIC 7.89%
ROICexc 8.09%
ROICexgc 23.62%
OM 14.94%
PM (TTM) 11.78%
GM 37.15%
FCFM 13.69%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%
ROICexc(3y)6.58%
ROICexc(5y)6.25%
ROICexgc(3y)23.86%
ROICexgc(5y)23.9%
ROCE(3y)8.19%
ROCE(5y)7.69%
ROICexcg growth 3Y-13.87%
ROICexcg growth 5Y1.5%
ROICexc growth 3Y-4.43%
ROICexc growth 5Y10.29%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 3.43
Debt/EBITDA 2.41
Cap/Depr 64.38%
Cap/Sales 2.25%
Interest Coverage 250
Cash Conversion 86.48%
Profit Quality 116.21%
Current Ratio 0.96
Quick Ratio 0.81
Altman-Z 2.3
F-Score7
WACC7.25%
ROIC/WACC1.09
Cap/Depr(3y)65.14%
Cap/Depr(5y)62.93%
Cap/Sales(3y)2.17%
Cap/Sales(5y)2.16%
Profit Quality(3y)91.89%
Profit Quality(5y)135.07%
High Growth Momentum
Growth
EPS 1Y (TTM)15.13%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%5.13%
EPS Next Y-0.86%
EPS Next 2Y7.41%
EPS Next 3Y9.94%
EPS Next 5Y11.04%
Revenue 1Y (TTM)-20.76%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-15.27%
Revenue Next Year-11.14%
Revenue Next 2Y-3.5%
Revenue Next 3Y-1.12%
Revenue Next 5Y2.66%
EBIT growth 1Y57.46%
EBIT growth 3Y-4.81%
EBIT growth 5Y10.77%
EBIT Next Year14%
EBIT Next 3Y11.58%
EBIT Next 5Y9.3%
FCF growth 1Y165.36%
FCF growth 3Y-6.18%
FCF growth 5Y20.42%
OCF growth 1Y101.31%
OCF growth 3Y-5.6%
OCF growth 5Y11.44%